November 1, 2018
An upcoming meeting will give people with movement disorders a chance to tell Food and Drug Administration regulators their story – the story of their physical symptoms as well as their emotional ones.
October 16, 2018
Pregnant or breastfeeding women routinely use medication for everything from the common cold to epilepsy.
September 18, 2018
In Arkansas, 4,300 fewer people have health insurance through the state’s Medicaid program this week. Another 5,000 could face a similar fate next month. Why? They failed to meet the state’s Medicaid work requirements.
September 13, 2018
Given the Trump administration’s rapid succession of proposals, policy plans and regulatory developments, 2018 may well be the year of biosimilars policy.
September 7, 2018
When it comes to how to increase the development and utilization of biosimilars, the Food and Drug Administration is all ears. On Tuesday, the agency welcomed numerous physicians and experts to testify on competition and innovation in the biosimilars marketplace. And at least one physician identified a critical component in uptake: physician confidence.
August 30, 2018
Patient access developments didn’t stop for summer. As we head into fall, here are 10 quotes from the news items – and new materials – that kept the health policy conversation lively during summer 2018.
August 22, 2018
Last month, the federal government proposed changes to Medicare’s billing rules. The net effect: Doctors will spend less time with their patients. As a physician myself, I know that’s not necessarily a good thing.
August 16, 2018
Some 2 million Americans take blood thinners. Nearly 30 million have diabetes. Tens of thousands more treat heartburn or cancer with medication prescribed by their doctor. Chances are, these patients’ attention piques when they hear the medicine they take followed by “medical alert” or “warning” blaring from their television. Many, including senior citizens, might even abandon their prescribed medicines out of fear.
July 24, 2018
To import, or not to import? The question of whether to bring foreign, lower-priced versions of prescription drugs to the United States is back.
July 3, 2018
What can America learn at the crossroads of social media and clinical trials? At a recent National Institutes of Health workshop, one organization had a clear answer: powerful methods for heightening clinical trials awareness.
